Nagpur
08042754782
 Nagpur
08042754782
+918007161282

Femitraz 1mg (Anastrozole) Tablet In USA, UK, Canada Australia, UAE, Saudi Arabia South Africa

💊 Femitraz 1 mg Tablet | Anastrozole | Breast Cancer Treatment | Export Supplier


Femitraz 1 mg Tablet contains Anastrozole, a hormonal therapy used in the treatment of hormone receptor-positive (HR+) breast cancer in postmenopausal women. It works by inhibiting aromatase enzyme, reducing estrogen levels and slowing cancer growth.



🔹 Product Category
Oncology Medicine (Hormonal Therapy / Aromatase Inhibitor)



🔹 Composition
Anastrozole 1 mg



🔹 Indications
✔ Hormone Receptor-Positive (HR+) Breast Cancer
✔ Adjuvant and Advanced Breast Cancer Treatment



🔹 Key Benefits
✔ Reduces estrogen production
✔ Slows hormone-dependent tumor growth
✔ Oral therapy (patient-friendly)
✔ Widely used in breast cancer management



🔹 Dosage & Administration
✔ Oral tablet as prescribed
✔ Usually taken once daily
✔ Long-term therapy under medical supervision



🔹 Packaging
✔ Blister / Bottle Packaging
✔ Bulk Export Available
✔ Private Labeling Supported



🔹 Certifications
✔ WHO-GMP Certified
✔ COA & COPP Available



🌍 Target Export Markets & Cities

🇺🇸 USA: New York, Los Angeles, Houston
🇬🇧 UK: London, Manchester
🇦🇪 UAE: Dubai, Abu Dhabi
🇸🇬 Singapore: Singapore

🇮🇳 India: Mumbai, Delhi, Bangalore
🇵🇭 Philippines: Manila
🇻🇳 Vietnam: Ho Chi Minh City, Hanoi

🇿🇦 South Africa: Johannesburg, Cape Town
🇳🇬 Nigeria: Lagos, Abuja
🇰🇪 Kenya: Nairobi

🇧🇷 Brazil: São Paulo
🇲🇽 Mexico: Mexico City
🇵🇪 Peru: Lima



📍 Location: Nagpur, Maharashtra, India



📦 Product Catalogue Available
✔ Oncology Medicines
✔ HIV & Antiviral Medicines
✔ Specialty Pharmaceutical Products



📞 Instant Support – Call / WhatsApp Now
📲 +91 8007161282
📲 +91 9970011496

💬 Quick replies for urgent orders & inquiries!



🌐 Visit Our Official Websites
🔹 www.pacificmedicines.com
🔹 www.indocares.com
🔹 www.indiamedexport.com



📧 Business Enquiries & Bulk Orders
✉️ sales@pacificmedicines.com




#Anastrozole
#BreastCancerTreatment
#HormonalTherapy
#OncologyMedicines
#AromataseInhibitor
#PharmaExport
#GlobalPharma
#B2BHealthcare
#GenericPharma
#IndiaPharma

 2026-05-05T09:30:01

Keywords